Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 07:57:59 2024-04-16 am EDT			5-day change	1st Jan Change
26.33 ^EUR	-0.48%		-3.98%	-21.78%

10:31am	Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains	RE
Apr. 15	Eurozone Industrial Production Recovery Boosts German Stocks Amid Growing Tensions in Middle East	MT

BAYER AG : Warburg Research reaffirms its Buy rating

March 30, 2020 at 05:02 am EDT

In a research note, Warburg Research analyst Ulrich Huwald has maintained his recommendation on the stock with a Buy rating.. The target price remains unchanged at EUR 66.

Latest news about Bayer AG

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains	04:31am	RE
Eurozone Industrial Production Recovery Boosts German Stocks Amid Growing Tensions in Middle East	Apr. 15	MT
UBS Trims Bayer PT, Maintains Neutral Rating	Apr. 15	MT
BAYER AG : Barclays reaffirms its Neutral rating	Apr. 15	ZD
Nutrien Plans Exit From Argentina, Chile	Apr. 15	MT
BAYER : UBS lowers price target	Apr. 15	CF
BAYER AG : Gets a Neutral rating from JP Morgan	Apr. 15	ZD
BAYER : Another peer group tidy up	Apr. 14
Bayer's patent for blood thinner Xarelto invalid, UK court rules	Apr. 12	RE
BAYER AG : UBS sticks Neutral	Apr. 12	ZD
TV ratings: Future 'Charité' ends very weakly	Apr. 12	DP
Bayer and Hologic Collaborates to Deliver Contrast-Enhanced Mammography	Apr. 11	CI
Bayer: new Chief Scientific Officer at AskBio	Apr. 10	CF
Alphabet: AI collaboration with Google and Bayer	Apr. 10	CF
Bayer: collaboration with Google in radiology AI	Apr. 10	CF
Bayer and Google Cloud to Accelerate Development of AI-Powered Healthcare Applications for Radiologists	Apr. 09	CI
Germany leads European higher; ECB policy meet in focus	Apr. 08	RE
Bayer under pressure - glyphosate verdict only partially mitigated	Apr. 08	DP
Bayer to Appeal US Court Decision to Cut 60% Punitive Damages from Weedkiller Cancer Verdict	Apr. 08	MT
Dpa-AFX Overview: COMPANIES - The most important news of the weekend	Apr. 07	DP
Judge slashes Bayer $1.56 billion Roundup verdict to $611 million	Apr. 05	RE
Bayer must pay significantly less in Roundup lawsuit	Apr. 05	DP
Sector Update: Health Care Stocks Rise Late Afternoon	Apr. 05	MT
Dr. Reddy's Laboratories, Bayer Collaborate to Distribute Second Brand of Heart Failure Drug in India	Apr. 05	MT
Policy push for carbon removal credits lures finance, aviation	Apr. 05	RE

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).

Sector

Pharmaceuticals

Calendar

2024-04-26 - Annual General Meeting

Related indices

EURO STOXX 50 , STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

BAYER : Another peer group tidy up

April 14, 2024 at 03:26 pm EDT

Bayer AG: Not out of the woods yet

March 06, 2024 at 10:46 am EST

More Strategies

Ratings for Bayer AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

26.46 EUR

Average target price

37.62 EUR

Spread / Average Target

+42.17%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BAYER AG	-21.78%	27.64B
ELI LILLY AND COMPANY	+28.79%	676B
NOVO NORDISK A/S	+23.79%	559B
JOHNSON & JOHNSON	-5.84%	356B
MERCK & CO., INC.	+15.75%	320B
ABBVIE INC.	+4.32%	286B
ASTRAZENECA PLC	+3.30%	213B
NOVARTIS AG	+0.19%	207B
ROCHE HOLDING AG	-8.96%	199B
PFIZER, INC.	-10.00%	147B

Other Pharmaceuticals

Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

BAYER AG : Warburg Research reaffirms its Buy rating

Latest news about Bayer AG

Chart Bayer AG

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Bayer AG

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals